COVID vaccine labels to warn of rare heart risk
The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.
Jun 27, 2025
0
17
Cardiovascular Diseases: News and Research on Cardiomyopathies
MeSH tree: C14.280.238
Genetics of cardiomyopathy risk in childhood cancer survivors differ by age of onset, study shows
The relationship between genetic variants and the risk of late-onset cardiomyopathy remains poorly understood in survivors of childhood cancer despite being otherwise well established. Scientists from St. Jude Children's ...
Jun 21, 2025
0
25
Immune biomarker can predict heart damage risk from inhibitor drugs
New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint inhibitors.
Jun 20, 2025
0
15
In axing mRNA contract, Trump delivers another blow to US biosecurity, former officials say
The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health security officials said. They warned ...
Jun 11, 2025
0
16
A new method for studying mechanical proteins and their involvement in muscular disorders
A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), led by Jorge Alegre-Cebollada, has developed an innovative method, called TEVs-TTN, for studying the specific mechanical functions of proteins through ...
Jun 5, 2025
0
8
FDA warns of heart risk with Pfizer, Moderna COVID vaccines
The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.
May 22, 2025
0
61
FDA requires trials of COVID shots for healthy kids and adults
U.S. regulators will no longer approve COVID booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
May 20, 2025
0
18
US limits COVID boosters to over-65s or those at high risk
The United States will limit COVID-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical trials before offering shots to younger and healthier individuals, ...
May 20, 2025
0
16
Surgeons perform first heart-liver-kidney transplants in New York State
A team of Mount Sinai surgeons has performed the first heart-liver-kidney triple organ transplants in New York. They successfully completed two of these complex surgeries on patients from Westchester County, who have since ...
May 20, 2025
0
17
No cardiac safety concerns reported with a pharmaceutically manufactured cannabidiol formulation
A pharmaceutically produced cannabidiol formulation had a good overall safety profile, including cardiac safety, according to research presented at Heart Failure 2025.
May 17, 2025
0
25
